Patent · US Active

Sequence and chiral selectivity of DNA-drug interactions revealed by force spectroscopy

US9778249B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 25, 2015
Grant dateOct 3, 2017
Priority date
Expiry dateSep 25, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/20
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods of quantifying the efficiency of a drug molecule for its targeted receptor, using a differential binding force to quantify the efficiency of a drug molecule to its targeted receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.